FALZETTI, Franca
 Distribuzione geografica
Continente #
NA - Nord America 2.441
EU - Europa 2.045
AS - Asia 852
SA - Sud America 26
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 5.370
Nazione #
US - Stati Uniti d'America 2.431
IT - Italia 569
IE - Irlanda 444
SG - Singapore 330
UA - Ucraina 241
SE - Svezia 218
HK - Hong Kong 196
CN - Cina 157
DE - Germania 139
FI - Finlandia 118
VN - Vietnam 86
RU - Federazione Russa 79
GB - Regno Unito 60
FR - Francia 44
RO - Romania 40
KR - Corea 33
BE - Belgio 24
BR - Brasile 23
TR - Turchia 22
CZ - Repubblica Ceca 20
NL - Olanda 13
AT - Austria 10
UZ - Uzbekistan 10
CH - Svizzera 9
IN - India 8
CA - Canada 5
LB - Libano 5
MX - Messico 5
PL - Polonia 5
GR - Grecia 4
AU - Australia 2
EC - Ecuador 2
ES - Italia 2
EU - Europa 2
BD - Bangladesh 1
BG - Bulgaria 1
CI - Costa d'Avorio 1
CL - Cile 1
DK - Danimarca 1
GE - Georgia 1
GH - Ghana 1
ID - Indonesia 1
IL - Israele 1
IM - Isola di Man 1
LT - Lituania 1
LV - Lettonia 1
PT - Portogallo 1
TW - Taiwan 1
Totale 5.370
Città #
Chandler 499
Dublin 444
San Mateo 299
Perugia 266
Singapore 244
Hong Kong 196
Boardman 157
Jacksonville 136
Ann Arbor 111
Santa Clara 100
Dong Ket 86
Medford 85
Princeton 83
Altamura 78
Andover 69
Beijing 61
Lawrence 58
Wilmington 55
Helsinki 47
Bucharest 40
Seoul 33
Foligno 27
Brussels 24
Houston 24
Los Angeles 24
Saint Petersburg 24
New York 23
Dearborn 22
Munich 22
Ashburn 21
Des Moines 21
Izmir 21
Redwood City 21
Norwalk 20
Brno 16
Dallas 16
Bologna 13
San Paolo di Civitate 13
Shanghai 11
Assisi 10
Falls Church 10
Redmond 10
West Jordan 10
Woodbridge 10
Auburn Hills 8
Groningen 8
Moscow 8
Florence 6
Padova 6
Rome 6
Espoo 5
Milan 5
Vienna 5
Bastia 4
Marsciano 4
Spello 4
Trieste 4
Ancona 3
Aurora 3
Den Haag 3
Frankfurt Am Main 3
Gradara 3
Guangzhou 3
London 3
Olomouc 3
Ottawa 3
Scafa 3
Vigodarzere 3
Amsterdam 2
Bengaluru 2
Changsha 2
Chicago 2
Council Bluffs 2
Delhi 2
Kunming 2
Ludwigshafen 2
Macerata 2
Melissa 2
Mexico City 2
Mirano 2
Naples 2
Nuremberg 2
Santarcangelo di Romagna 2
Selargius 2
São José dos Campos 2
São Paulo 2
Tashkent 2
Abidjan 1
Ahmedabad 1
Allentown 1
Apo 1
Athens 1
Battipaglia 1
Bekasi 1
Brodósqui 1
Cagliari 1
Campo Largo 1
Campobasso 1
Castiglione del Lago 1
Catania 1
Totale 3.717
Nome #
Bepridil exhibits anti-leukemic activity associated with NOTCH1 pathway inhibition in chronic lymphocytic leukemia 131
Advances in full-haplotype mismatched transplants in acute leukemia 128
Constitutive phosphorylation of the active Notch1 intracellular domain in chronic lymphocytic leukemia cells with NOTCH1 mutation. 119
Engineering donor mesenchymal cells with IL-7 hastens naive T cell recruitment. 117
Notch1 modulates mesenchymal stem cells mediated regulatory T-cell induction 110
Engineering donor mesenchymal cells with IL-7 hastens naive T cell recruitment in vitro and supports immunologic reconstitution after HSCT in NOD/SCID mice 99
In Vivo Real Time Monitoring of Stem Cells Homing in Postischemic Tissues 94
Mesenchymal cells: a vehicle for gene therapy 93
Activated autologous T cells exert an anti-B-cell chronic lymphatic leukemia effect in vitro and in vivo. 93
Graft engineering for allogeneic haploidentical stem cell transplantation 89
Notch signaling sustains the expression of Mcl-1 and the activity of eIF4E to promote cell survival in CLL 84
IN VIVO DIRECT MONITORING OF STEM CELLS HOMING IN POSTISCHEMIC TISSUES 83
γ-Secretase inhibitor I induces apoptosis in chronic lymphocytic leukemia cells by proteasome inhibition, endoplasmic reticulum stress increase and Notch down-regulation. 82
The NOTCH1/CD39 axis: A Treg trip-switch for GvHD 82
NPM1 AND FLT3-ITD MUTATIONS SINERGISTICALLY INDUCE GATA1 EPIGENETIC SILENCING IN A AML MOUSE MODEL 77
Targeting Mutant BRAF in Relapsed or Refractory Hairy-Cell Leukemia 76
A new genetic lesion in B-CLL: a NOTCH1 PEST domain mutation. 75
Engineering mesenchymal cells with interleukin 7 gene: effects on T cell. 18-23. 75
Clinical-Grade Expanded Regulatory T Cells Prevent Graft-versus-Host Disease While Allowing a Powerful T Cell Dependent Graft-versus-Leukemia Effect in Murine Models 74
Addition of PBPCs to the marrow inoculum allows engraftment of mismatched T cell-depleted transplants for acute leukemia 73
NOTCH1 Aberrations in Chronic Lymphocytic Leukemia. 72
Chronic myeloproliferative disorders: the bone marrow stromal component is not involved in the malignant clone.Di Ianni M, Moretti L, Del Papa B, De Ioanni M, Bonifacio E, Falzetti F, Tabilio A. 72
Decreased NOTCH1 Activation Correlates with Response to Ibrutinib in Chronic Lymphocytic Leukemia 72
Haploidentical hematopoietic transplantation from KIR ligand-mismatched donors with activating KIRs reduces nonrelapse mortality 71
NOTCH1 Is Aberrantly Activated in Chronic Lymphocytic Leukemia Hematopoietic Stem Cells. 71
GATA1 epigenetic deregulation contributes to the development of AML with NPM1 and FLT3-ITD cooperating mutations 71
Full haplotype-mismatched hematopoietic stem-cell transplantation: A phase II study in patients with acute leukemia at high risk of relapse 71
Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation. 69
A novel NOTCH1 PEST domain mutation in a case of Chronic Lymphocytic Leukemia 69
NPM1 AND FLT3-ITD MUTATIONS COOPERATE TO IMPAIR HEMATOPOIETIC STEM/PROGENITOR CELLS DIFFERENTIATION AND DEREGULATE GATA1 IN A MOUSE MODEL OF AML 68
T regulatory cell separation for clinical application. 68
Full-haplotype mismatched HSCT for high risk acute myeloid leukemia (AML). 66
"Designed" grafts for HLA-haploidentical stem cell transplantation. 65
Novel targets for endoplasmic reticulum stress-induced apoptosis in B-CLL. 64
Stem cell mobilization in normal donors. 63
Hematopoietic stem cell transplantation (HSCT) from alternative donors for acute leukemia at high-risk of relapse. the haploidentical option. 62
Effetto della severità dell'ischemia sul reclutamento delle cellule staminali nei tessuti postischemici: monitoraggio diretto in vivo mediante videomicroscopia 62
Ibrutinib treatment of a patient with relapsing chronic lymphocytic leukemia and sustained remission of Richter syndrome 62
Dactinomycin induces complete remission associated with nucleolar stress response in relapsed/refractory NPM1-mutated AML 61
Effetto della severità dell’ischemia sul reclutamento delle cellule staminali nei tessuti postischemici: monitoraggio diretto in vivo mediante videomicrosopia. 60
A revised NOTCH1 mutation frequency still impacts survival while the allele burden predicts early progression in chronic lymphocytic leukemia 60
IL-4-dependent Jagged1 expression/processing is associated with survival of chronic lymphocytic leukemia cells but not with Notch activation. 60
IN VITRO AND IN VIVO ANTILEUKEMIC ACTIVITY OF BEPRIDIL IN CHRONIC LYMPHOCYTIC LEUKEMIA IS ASSOCIATED WITH INHIBITION OF THE NOTCH1 PATHWAY 59
Full haplotype mismatched transplant in high risk acute leukemia patients. 58
Mismatched hematopoietic stem cell transplantation in secondary leukemia 58
NOTCH1 PEST domain mutation is an adverse prognostic factor in B-CLL. 58
A microelectronic DNA chip detects the V617F JAK-2 mutation in myeloproliferative disorders 58
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse 57
The Total Body Irradiation Schedule Affects Acute Leukemia Relapse After Matched T Cell–Depleted Hematopoietic Stem Cell Transplantation 56
MYB deregulation from a EWSR1-MYB fusion at leukemic evolution of a JAK2 V617F positive primary myelofibrosis 56
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse 56
Interleukin-7-engineered mesenchymal cells: in vitro effects on naive T-cell population. 54
Stem cell transplantation from full-haplotype mismatched donors in leukemia . 53
Distribution of active alpha and beta subunit of beta-N-acetylhexosaminidase as a function of leukaemic cell types 53
The human NPM1 mutation A perturbs megakaryopoiesis in a conditional mouse model. 53
Cytogenetic/mutation profile of chronic lymphocytic leukemia/malignant melanoma collision tumors of the skin 53
. Mismatched hematopoietic stem cell transplants in elderly patients. 53
Enhancing Regulatory T Cell Function and Homing to the Gut to Improve graft-versus-host Disease Prevention after Adoptive Transfer in Allogeneic Hematopoietic Transplantation 52
New mechanism of lymphoma-induced bone marrow aplasia 52
Novel NPM1 exon 5 mutations and gene fusions leading to aberrant cytoplasmic nucleophosmin in AML 52
Identification and Characterization of Novel Rare Nucleophosmin (NPM1) Gene Mutations in Acute Myeloid Leukemia (AML) By a Combinatorial Approach of Immunohistochemistry and Molecular Analyses 51
THE BRAF INHIBITOR VEMURAFENIB IS SAFE AND HIGHLY EFFECTIVE IN REFRACTORY AND RELAPSED HAIRY CELL LEUKEMIA: RESULTS OF THE HCL-PG01 PHASE-2 ITALIAN CLINICAL TRIAL 51
NOTCH and NF-κB interplay in chronic lymphocytic leukemia is independent of genetic lesion. 51
Nephrotic syndrome in primary myelofibrosis with renal extramedullary hematopoiesis and glomerulopathy in the JAK inhibitor era 49
Reclutamento delle cellule staminali nei tessuti postischemici: valutazione diretta in vivo mediante videomicroscopia 49
MOLECULAR AND BIOLOGICAL BASIS OF THE ASOCIATION OF RADIOTHERAPY, 5-FLUOROURACIL AND GEFITINIB IN RECTAL CANCER 49
Haploidentical age-adapted myeloablative transplant and regulatory and effector T cells for acute myeloid leukemia 48
Mesenchymal cells recruit and regulate T regulatory cells. 47
Hematopoietic stem cell transplantation from alternative donors for high-risk acute leukemia: the haploidentical option. 46
The “ultimate” haploidentical transplantation for the elderly with high-risk acute myeloid leukemia 46
Activation of Regulatory T Cells with IL-2 and TNF-alpha to Promote Homing to the Gut and to Improve Acute GvHD Prevention 45
BEPRIDIL IS A POTENT NOTCH1 INHIBITOR AND EFFICIENTLY INDUCES APOPTOSIS IN CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL) CELLS in vitro AND in vivo 44
Outcomes after CD34+ positive immunoselection for haploidentical transplants in high-risk acute leukemia. 44
Prognostic significance of genetic variants in the IL-23/Th17 pathway for the outcome of T cell-depleted allogeneic stem cell transplantation. 44
Full-haplotype mismatched HSCT is a valid option for high-risk acute myeloid leukemia (AML) patients. 44
Homing and survival of thymidine kinase-transduced human T cells in NOD/SCID mice 42
Immunoselection and clinical use of T regulatory cells in HLA-haploidentical stem cell transplantation. 41
Trapianto di cellule staminali nei tessuti post-ischemici: studio in vivo degli effetti delle cellule staminali sulla funzione microvascolare. 41
Gefitinib enhances the effects of combined radiotherapy and 5-fluorouracil in a colorectal cancer cell line. 40
null 37
Haploidentical hematopoietic transplantation from KIR ligand-mismatched donors with activating KIRs reduces non-relapse mortality 34
Radioimmunotherapy with 90Y-ibritumomab tiuxetan to treat follicular non Hodgkin-lymphoma in relapse after autologous transplant or refractory to chemotherapy: preliminary results. 34
NOTCH and Graft-Versus-Host Disease 34
Hematopoietic stem cell transplantation from alternative donors for high-risk acute leukemia: the haploidentical option. 33
Homing and survival of thimidine kinase transduced human T-cells in NOD/SCID mice. 33
Next generation HLA-haploidentical HSCT 31
HAPLOIDENTICAL TRANSPLANTATION WITH TREG-TCON ADOPTIVE IMMUNOTHERAPY FOR THE CURE OF ACUTE MYELOID LEUKEMIA WITH HIGH-RISK CYTOGENETICS 30
Acute GvHD after HLA- Haploidentical Hematopoietic Cell Transplantation with Regulatory and Conventional T Cell Immunotherapy Does Not Adversely Affect Transplantation Outcomes 30
Uno strano caso di “eritema pernio” delle mani 28
NOTCH1 Aberrant Activation Is a Common Nonmutational Early Event in Chronic Lymphocytic Leukemia Hematopoietic Stem-Cells 28
A pro-inflammatory environment in bone marrow of Treg transplanted patients matches with graft-versus-leukemia effect 27
ADOPTIVE IMMUNOTHERAPY WITH REGULATORY AND CONVENTIONAL T CELLS AFFORDS HIGH RATE OF CHRONIC GVHD/RELAPSE-FREE SURVIVAL IN ACUTE MYELOID LEUKEMIA AFTER MYELOABLATIVE HAPLOIDENTICAL TRANSPLANTATION 27
Regulatory T Cell Adoptive Immunotherapy Promotes B Cell Immunity after Haploidentical Transplantation 26
REGULATORY T CELL ADOPTIVE IMMUNOTHERAPY PROMOTES B CELL IMMUNITY AFTER HAPLOIDENTICAL TRANSPLANTATION 20
Totale 5.628
Categoria #
all - tutte 25.750
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.750


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020232 0 0 0 0 0 0 0 19 56 102 14 41
2020/2021690 12 33 32 35 194 58 51 12 78 26 59 100
2021/2022974 18 252 18 43 22 10 14 223 12 77 138 147
2022/20231.471 89 275 15 129 119 150 0 61 558 6 49 20
2023/2024746 30 69 37 29 3 20 178 9 46 38 128 159
2024/2025708 60 141 60 76 198 52 91 30 0 0 0 0
Totale 5.628